{"id":"5e5add5f-ab9f-5f8f-a517-8ba700600967","stable_key":"3b5aff9b-4086-5574-bfb4-3ea49ba520d7:coq10-nephropathy-proteinuria","predicate":"associated_with_reduction_in","statement":"Median protein-to-creatinine ratio fell from 1.66 to 0.19 g/gCr at 12 months; six of seven patients with 12-month data had at least a 50% reduction.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"83844e89-586e-561e-8a5d-376e23c60ee6","mechanism_event_label":"The treatment signal was in a genetically defined disease, not routine tiredness.","subject":{"id":"f1bcf0ac-3578-5afa-97d7-ef3551b657c5","slug":"coq10","display_name":"Coenzyme Q10 / CoQ10 redox system","entity_type_key":"chemical_species"},"object":{"id":"6a774e8d-e38b-5551-a50c-e8afe2b518aa","slug":"proteinuria","display_name":"Urinary protein excretion / proteinuria","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"83844e89-586e-561e-8a5d-376e23c60ee6","stable_key":"3b5aff9b-4086-5574-bfb4-3ea49ba520d7:coq10-nephropathy-proteinuria-event","event_type":"observed_intervention","label":"The treatment signal was in a genetically defined disease, not routine tiredness.","description":"Median protein-to-creatinine ratio fell from 1.66 to 0.19 g/gCr at 12 months; six of seven patients with 12-month data had at least a 50% reduction.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"1c3f171e-e5c6-5347-ae2d-3c0e6580fc47","slug":"coq8b","display_name":"Human COQ8B / ADCK4","entity_type_key":"protein"},"role":"predominant_disease_gene","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"72ad4a49-5bb2-5caa-884b-20d65c271c0f","slug":"coq6","display_name":"Human CoQ monooxygenase / COQ6","entity_type_key":"protein"},"role":"other_disease_gene","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"f1bcf0ac-3578-5afa-97d7-ef3551b657c5","slug":"coq10","display_name":"Coenzyme Q10 / CoQ10 redox system","entity_type_key":"chemical_species"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"6a774e8d-e38b-5551-a50c-e8afe2b518aa","slug":"proteinuria","display_name":"Urinary protein excretion / proteinuria","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""}]},"contexts":[{"dimension":"availability_state","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null},{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/coq10-research/42435122.abstract.txt\", \"locator\": \"Primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"59862dedc0e8ce5d72cf95f5f04a1d16e447cc16e9f2310fac81d15fb1fa9aa4\", \"start_char\": 0, \"end_char\": 1715, \"text_sha256\": \"59862dedc0e8ce5d72cf95f5f04a1d16e447cc16e9f2310fac81d15fb1fa9aa4\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Retrospective longitudinal clinical cohort","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"CoQ supplementation; median initial dose 10 mg/kg/day","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"2026 observational cohort without untreated randomization; incomplete 12-month data and genotype-specific context.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Coenzyme Q10 research collection; topical membership is not evidence of a direct dietary effect.","comparator":null,"unit":null,"notes":"","entity":{"slug":"coq10","display_name":"Coenzyme Q10 / CoQ10 redox system","entity_type_key":"chemical_species"}},{"dimension":"organism","value_text":"12 Japanese patients: 11 COQ8B and one COQ6","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"The treatment signal was in a genetically defined disease, not routine tiredness.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[coq10-p42435122] Kidney outcomes of coenzyme Q10 supplementation in patients with genetically confirmed CoQ10 nephropathy in Japan. (2026). https://pubmed.ncbi.nlm.nih.gov/42435122/ DOI: 10.1007/s10157-026-02917-7","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Genetically confirmed CoQ nephropathy","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"trigger_kind","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null}],"evidence":[{"id":"638a50ae-b364-5861-90f0-d70aefee1dbe","evidence_kind":"source_excerpt","locator":"Lines 1048-1059","start_line":1048,"end_line":1059,"excerpt":"### coq10-nephropathy-proteinuria\nMedian protein-to-creatinine ratio fell from 1.66 to 0.19 g/gCr at 12 months; six of seven patients with 12-month data had at least a 50% reduction.\nCondition category: machinery_impairment\nnutrient_topic: Coenzyme Q10 research collection; topical membership is not evidence of a direct dietary effect.\nplain_language: The treatment signal was in a genetically defined disease, not routine tiredness.\norganism: 12 Japanese patients: 11 COQ8B and one COQ6\ntissue_or_cell_type: Genetically confirmed CoQ nephropathy\nexperimental_model: Retrospective longitudinal clinical cohort\nlimitations: 2026 observational cohort without untreated randomization; incomplete 12-month data and genotype-specific context.\nexposure: CoQ supplementation; median initial dose 10 mg/kg/day\nevidence_span: {\"source_cache\": \"artifacts/coq10-research/42435122.abstract.txt\", \"locator\": \"Primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"59862dedc0e8ce5d72cf95f5f04a1d16e447cc16e9f2310fac81d15fb1fa9aa4\", \"start_char\": 0, \"end_char\": 1715, \"text_sha256\": \"59862dedc0e8ce5d72cf95f5f04a1d16e447cc16e9f2310fac81d15fb1fa9aa4\"}\n[coq10-p42435122] Kidney outcomes of coenzyme Q10 supplementation in patients with genetically confirmed CoQ10 nephropathy in Japan. (2026). https://pubmed.ncbi.nlm.nih.gov/42435122/ DOI: 10.1007/s10157-026-02917-7","model_system":"Retrospective longitudinal clinical cohort","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [coq10-p42435122] Kidney outcomes of coenzyme Q10 supplementation in patients with genetically confirmed CoQ10 nephropathy in Japan. (2026). https://pubmed.ncbi.nlm.nih.gov/42435122/ DOI: 10.1007/s10157-026-02917-7","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"fc6c2f3b-14a3-59de-848e-ca1c02fee1df","stable_key":"import-3b5aff9b-4086-5574-bfb4-3ea49ba520d7","title":"Coenzyme Q10: biosynthesis, electron transfer, antioxidant recycling and nutrient interactions (2026-09-17)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"053f9a6f6c17321fa9fd271486d7f20a86a49b237424108de7dc8663372e73bf","revision_id":"028900ce-8ca4-5d13-8c86-6e327c071e64","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}